Comparative Pharmacology
Head-to-head clinical analysis: AMIKIN versus GENTACIDIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMIKIN versus GENTACIDIN.
AMIKIN vs GENTACIDIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Aminoglycoside antibiotic that binds to the 30S ribosomal subunit, causing misreading of mRNA and inhibition of protein synthesis.
Aminoglycoside antibiotic that binds to the 30S ribosomal subunit, causing misreading of mRNA and inhibiting protein synthesis.
15 mg/kg/day IV or IM divided every 8 to 12 hours; usual adult dose: 15 mg/kg/day
5-7 mg/kg IV every 24 hours.
None Documented
None Documented
2-3 hours in adults with normal renal function; prolonged to 30-90 hours in ESRD.
2-3 hours in adults with normal renal function; extended to 24-48 hours in anuria or severe renal impairment, requiring dose adjustment.
Renal: >90% unchanged in urine via glomerular filtration; biliary/fecal: <1%.
Renal: 95-98% unchanged via glomerular filtration; biliary/fecal: <2%.
Category C
Category C
Aminoglycoside Antibiotic
Aminoglycoside Antibiotic